GPBAR1 and Insulin resistance: Furthermore, TGR5 activation induces the release of glucagon-like peptide-1 (GLP-1) by enteroendocrine L cells and the colon, thereby protecting against insulin resistance and improving glucose tolerance in obese mice [7–10].